Metastatic tumor of the left atrium (RCD code: VI‑2O)
Journal Title: Journal of Rare Cardiovascular Diseases - Year 2016, Vol 2, Issue 6
Abstract
We present a case report concerning a 59-year-old patient diagnosed with intracardiac tumor two years after removal of soft tissue sarcoma of the right lower extremity.
Authors and Affiliations
Zbigniew Gąsior, Katarzyna Mizia-Stec, Maria Kasztelan-Masłowska, Mariusz Skowerski, Krzysztof Januszewski, Piotr Pysz
Keywords
Related Articles
- EP ID EP248099
- DOI 10.20418/jrcd.vol2no6.213
- Views 101
- Downloads 0
Transradial carotid artery stenting with the use of a novel integrated embolic protection technology
We present the case of a 79‑year‑old woman with critical right internal carotid artery stenosis in whom carotid artery stenting was performed via a right radial artery approach with the use of a novel integrated embolic...
Left ventricular non‐compaction – diagnostic challenges
Left ventricular non‐compaction (LVNC), or “spongy myocardium”, is a rare cardiac morphological condition detected in 0.05–0.26% of all adults undergoing transthoracic echocardiography, with an increasing prevalence in t...
Patent ductus arteriosus recanalization following its successful surgical closure (RCD code: IV-2B.4)
Patent ductus arteriosus (PDA) is rarely diagnosed late in adult life, and frequently in children as an isolated disorder or complex congenital heart defect. PDA represents an anomaly defined by the communication between...
Arrhythmias in pregnancy (RCD code: VII‑V)
Cardiovascular diseases in pregnancy are the most common causes of maternal mortality in developed world and an important cause of heart failure, stroke, and arrhythmia. Cardiac disease complicates 0.4–4% of all pregnanc...
Establishing the optimal dose of nitric oxide in acute vasoreactivity testing in patients with pulmonary hypertension with use of the Bronchial Control Treatment System (RCD code: II)
The key point in the diagnostic algorithm for pulmonary hypertension plays the pulmonary reactivity testing, the agent most frequently used in the test is inhaled nitric oxide (iNO). Various dosages of iNO were used in a...